APOE-epsilon ε4 allele ε4ε4 haplotype Aging Lead Age-related Cognitive decline a b s t r a c t Background: Continuing chronic and sporadic high-level of lead exposure in some regions in the U.S. has directed public attention to the effects of lead on human health. Long-term lead exposure has been associated with faster cognitive decline in older individuals; however, genetic susceptibility to leadrelated cognitive decline during aging has been poorly studied. Methods: We determined the interaction of APOE-epsilon variants and environmental lead exposure in relation to age-related cognitive decline. We measured tibia bone lead by K-shell-x-ray fluorescence, APOE-epsilon variants by multiplex PCR and global cognitive z-scores in 489 men from the VA-Normative Aging Study. To determine global cognitive z-scores we incorporated multiple cognitive assessments, including word list memory task, digit span backwards, verbal fluency test, sum of drawings, and pattern comparison task, which were assessed at multiple visits. We used linear mixed-effect models with random intercepts for individual and for cognitive test.
Introduction
By 2020 as many as 42 million individuals worldwide will suffer from dementia, and that number is expected to double by 2040 (Rizzi et al., 2014) . Although lead exposure has reduced in the last decades, a very recent state of emergency has been declared in Flint, Michigan, U.S. because of high-levels of lead in drinking water, which has highlighted the importance of lead exposure in public health (Wang, 2015) . Lead has been repeatedly associated with adverse cognitive effects both in children and older individuals (Koller et al., 2004; Wright et al., 2003) , due to occupational (ATSDR, 2007) and environmental exposures (Weisskopf et al., 2007) . However, very few susceptibility biomarkers are available to predict the impact of environmental toxicants, including lead exposure, on age-related cognitive decline. Availability of such biomarkers is critical to design targeted preventive strategies on those at risk, and to reduce the burden of Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/envres cognitive impairment during aging. Apolipoprotein E (APOE) epsilon-4 allele (ε4), is one of the best known genetic risk markers for cognitive function impairment and Alzheimer's disease (Liu et al., 2013) . Few studies have evaluated the role of genetic susceptibility in the cognitive effects of environmental lead exposures (Wang et al., 2007) , and while a prior study addressed occupational lead exposure (Stewart et al., 2002) , no previous environmental study has evaluated the role of the APOE ε4 allele. In this study, we evaluated whether the APOE epsilon alleles modified the association between tibia bone lead and global cognitive function in a cohort of male participants aged 41-77 years (mean: 58.58, SD: 6.52 yrs) at baseline in the Veterans Affairs (VA) -Normative Aging Study (NAS).
Material and methods

Participants
The present analysis was conducted on 489 elderly men from the VA -NAS (Bell et al., 1966) . NAS was approved by the Institutional Review Boards (IRB) at participating institutions and participants have provided written informed consent at each visit.
Bone lead measurements and APOE ε4 genotyping
We focused our analysis in tibia lead (cortical bone) as its halflife estimates may reach up to 20 years (Hu et al., 1998) . Tibia lead measurements were performed on average 1.6 times per participant (SD: 0.74, min ¼ 1, max ¼4) at the mid-tibial shaft by K-shell x-ray fluorescence with an ABIOMED KXRF, and we used the closest measurement to cognitive evaluation for analysis. APOE epsilon variants were determined as previously described (Prada et al., 2014) .
Neuropsychological testing
For cognitive performance, we evaluated "total" cognitive function integrating multiple cognitive tests (Table 1) . Cognitive data were collected at multiple visits approximately 3.6 years apart, with nearly 2.7 visits (min ¼1, max¼ 7) per subject and 3566 visits in total were included, from 1993 to 2004.
Data analysis
We assessed the association between tibia lead and "total" cognitive function by incorporating the multiple cognitive assessments at multiple visits, and treating each cognitive score as a repeat measure of underlying overall cognition. We used linear mixed-effect models with random intercepts for individual and for cognitive test, determining association with global cognitive decline. Also, to determine the effect of lead on overall cognition as well as the interaction of APOE epsilon variants, we explored the association using only the first cognitive assessment. To determine effect modification by APOE epsilon variants in the association of tibia lead with overall cognitive change, we added multiplicative interaction terms. We adjusted for age at cognitive assessments, education 6-11, 12-16, 416 years of education), first language (English, not English), computer experience (yes, no), smoking status (never, current, former), physical activity (o12, 12-30, and 430 metabolic equivalent hours) (Jetté et al., 1990) , alcohol intake (o2 or Z2 drinks/day), diabetes (self-reported or having fasting glucose above 126 mg/dl) and census tract percentages of the participants that are non-white and with at least a college degree. All tests were two-sided and p-values o0.05 were considered (Fillenbaum et al., 2008) Delayed recall Recall of the 10 words presented after 5-10 min delay. One trial.
Digit span backwards
Numbers recall (Standard score) Repeat from 3 to 8 digits in reverse orally. The maximum number of digits correctly repeated is the score.
Wechsler Adult Intelligence Scale-Revised, WAIS-R Executive function (Wechsler, 1981) Verbal fluency test Total number of animals named Say as many words as possible from a category (animals) in 60″. Consortium to Establish a Registry for Alzheimer Disease, CERAD Language (Fillenbaum et al., 2008) Sum of drawings Sum of drawings Copy circle, rectangles, diamond, and cube. Accuracy of copied forms.
Consortium to Establish a Registry for Alzheimer
Disease, CERAD Visospatial ability (Fillenbaum et al., 2008) Pattern comparison task Mean response time Discern whether two sided pictures are the same or not.
Neurobehavioral Evaluation System 2, NES2
Executive function (Letz, 1991) Number correct significant. We used SAS software (Version 9.3, SAS Institute Inc., Cary, NC) for all statistical analyses.
Results
Most of the men were former smokers (55.8%), reported between 12 and 16 years of education (51.9%), exhibited overweight or obesity (79.7%), and were Caucasian (95%). Additional characteristics at baseline by subgroups and bone levels are shown in Table 2 . Lower levels of lead were observed in younger, more educated men and in those who had computer experience (Table 2). At least one ε4 allele was observed in 23.0% of men and the ε4ε4 haplotype was observed in 2.7% (Table 3) Haplotype ε1ε2 was observed in only 2 individuals and included in the 'None' ε4 allele group for analysis. No differences in tibia lead levels were observed among APOE haplotypes (p ¼0.27 for analysis of variance of tibia lead levels between allelic groups; p ¼0.09 for haplotypes).
We did not observe association between APOE haplotype or APOE ε4 allele status on cognitive change (Supp. (Table 4 ). Additive models of APOE ε4 allele status showed that in carriers of both APOE ε4 alleles, one IQR increase in tibia lead was associated with 0.57 (95%CI: À 0.97 to À 0.16) lower point total cognition z-score.
In the presence of only one APOE ε4 allele, a borderline association was observed (Estimate effect per 1-IQR increase: À 0.11, 95%CI:
À 0.22, 0.01). When APOE ε4 allele was absent, there was little evidence of an association between lead and cognition (Estimate effect per 1-IQR increase: À 0.04, 95%CI: À 0.09 to 0.02) ( Table 4 ).
In analyses considering APOE haplotypes, ε4ε4 carriers had a 0.57 lower points total cognition z-score (95%CI: À0.97 to À 0.16) for each IQR increase in tibia lead. Also, ε4ε4 showed an interaction in the association between tibia lead and total cognition z-score (pvalue for interaction ¼0.010) ( haplotypes ¼0.09 (Table 4) . Cross-sectional analysis -using only the first cognitive assessment-to determine the impact on global cognition, showed a lack of effect of lead on cognitive performance (Estimate effect per 1-IQR increase¼ 0.004, 95%CI À 0.058 to 0.067). A borderline effect on carriers of both APOE ε4 alleles was observed (Estimate effect per 1-IQR increase ¼ À1.14, 95%CI À 2.29 to 0.01). No association was found in the presence of only one or in absence of APOE ε4 allele (Supp. Table 2 ). We also tested the role of age in the interaction observed for APOE ε4 allele, but no significant association was observed (Supp. Table 3 ).
Discussion
In this cohort of aging men, we found that the association of bone lead with age-related cognitive decline was stronger in APOE ε4 allele carriers, with the strongest statistically significant association in those with two copies of the allele. To the best of our knowledge, this is the first report of a potential interaction of APOE ε4 allele with environmental lead exposure in relation to cognitive decline in elderly individuals.
Several studies have associated cognitive impairment with lowlevel lead exposure (Weisskopf et al., 2004) . One previous crosssectional analysis in former organolead workers found interaction (p o0.05) of APOE ε4 in three out of 20 cognitive tests (Stewart et al., 2002) . This study was also cross sectional and the interaction between APOE ε4 and lead for cognitive decline was not assessed.
The mechanisms linking lead and cognitive function are unknown; however, neural dysfunction has been attributed to lead's ability to substitute for calcium, which plays a central role in synapsis, mitochondria function, among other cellular processes (White et al., 2007) . APOE ε4 genetic variants have been repeatedly associated with impaired cognition in the elderly and individuals with APOE genetic susceptibility show more pronounced age-related reduction in hippocampal volume (Lind et al., 2006) , decreased antioxidant capacity (Miyata and Smith, 1996) , and altered use of nutrients (Reiman et al., 2004) . All those characteristics may make APOE ε4 carriers more susceptible to lead-induced neuroinflammation. Previous studies have found that other genetic susceptibilities may also modify the rate of lead-related cognitive decline (Wilker et al., 2011) . In our study, we also found the presence of haplotypes showing the ε1 allele (haplotypes ε1ε2 and ε1ε4). Scientific literature is full of data claiming that APOE ε1 allele is a very rare allele, even to the point of considering it almost as 'inexistent' in the clinical practice. However, this comment is related to the ε1ε1 condition, which was not observed in our population (Steinmetz et al., 1990 ). We did not find haplotype ε2ε4, which has also been reported in very low frequencies in similar epidemiological studies (Koopal et al., 2016) .
Our study has several limitations: the study participants are male Caucasians and our results may not apply to other ethnic groups, e.g. APOE ε4 have showed an attenuated effect in Hispanics (Farrer et al., 1997) . Also, although most evidence suggests APOE ε4 effect is stronger in women, (Ungar et al., 2014 ) the APOEgender interaction remains controversial (Qiu et al., 2004) . Also, non-differential misclassification of cognitive status is likely, but reduced by our use of all available cognitive data as a measure of age-related cognitive decline. Also, the number of individuals with APOE ε4ε4 haplotype is small (N ¼ 13), and it could bias our finding and give rise to the possibility of type-1 error. However, very few cohorts worldwide have determined concomitantly bone lead, APOE genotype, and have assessed cognitive function longitudinally during aging, and including several variables involved in cognitive performance during aging.
Conclusions
In summary, elderly men with two copies of the APOE ε4 allele showed greater cognitive decline associated with lead exposure. Based on the long retention of lead in the body, the rapid growth of older populations in modern societies and the special susceptibility to chronic low-levels of lead exposure in some minorities and socioeconomically disadvantaged groups, our findings stress the need to control lead to protect cognitive function in the elderly.
